Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Ltd (SANOFICONR) last reported results for the quarter ended Jun 2026, with sales of ₹236 crore and net profit of ₹69 crore. The stock last traded at ₹3,703, a market capitalisation of ₹8,528 crore, on a P/E of 32.1. Over the past 52 weeks the stock has ranged between ₹3,691 and ₹5,255. Figures are as of 6 Oct 2026 and are not real time.
Sanofi Consumer Healthcare India Ltd share price and key metrics
- Current price
- ₹3,703
- Market cap
- ₹8,528 cr
- Stock P/E
- 32.1
- Book value
- ₹151
- ROE
- 71.6%
- ROCE
- 89.9%
- Dividend yield
- 2.02%
- 52w high / low
- 5255/3691
Metrics as of 6 Oct 2026. Not real time.
Track Sanofi Consumer Healthcare India Ltd
Cruxal reads every Sanofi Consumer Healthcare India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Sanofi Consumer Healthcare India Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 31%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 34%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -22%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 78%
- Last Year
- 72%
Sanofi Consumer Healthcare India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹236 cr, up 6.8% from ₹221 cr a year earlier. Net profit was ₹69 cr, up 13.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 171 | 173 | 221 | 234 | 251 | 229 | 236 |
| Expenses | 97 | 109 | 109 | 151 | 149 | 161 | 140 | 146 |
| Operating profit | 63 | 62 | 64 | 70 | 85 | 90 | 89 | 89 |
| OPM % | 39% | 36% | 37% | 32% | 36% | 36% | 39% | 38% |
| Other income | 3 | 2 | 5 | 12 | 3 | 5 | 6 | 6 |
| Interest | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 61 | 63 | 67 | 79 | 84 | 90 | 91 | 92 |
| Tax % | 26% | 29% | 25% | 23% | 25% | 27% | 25% | 25% |
| Net profit | 45 | 44 | 50 | 61 | 63 | 66 | 68 | 69 |
| EPS (₹) | 19.54 | 19.24 | 21.71 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Sanofi Consumer Healthcare India Ltd annual results
| ₹ crore | Dec 2024 | Mar 2025 | Dec 2025 | TTM |
|---|---|---|---|---|
| Sales | 724 | 878 | 878 | 950 |
| Operating profit | 271 | 309 | 309 | 353 |
| OPM % | 37% | 35% | 35% | 37% |
| Net profit | 181 | 240 | 240 | 266 |
| EPS (₹) | 78.59 | 104.25 | 104.25 | 115.49 |
TTM is the trailing twelve months to the most recent quarter.
Sanofi Consumer Healthcare India Ltd balance sheet
| ₹ crore | Dec 2023 | Dec 2024 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|
| Equity capital | 2 | 23 | 23 | 23 |
| Reserves | 206 | 250 | 361 | 325 |
| Borrowings | 0 | 20 | 25 | 21 |
| Other liabilities | 138 | 138 | 138 | 338 |
| Total liabilities | 345 | 431 | 547 | 706 |
| Fixed assets | 5 | 29 | 36 | 30 |
| CWIP | 3 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other assets | 338 | 402 | 511 | 677 |
| Total assets | 345 | 431 | 547 | 706 |
As reported by the company. Total assets equal total liabilities by construction.
Sanofi Consumer Healthcare India Ltd cash flow
| ₹ crore | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | -0 | 439 | 175 |
| Cash from investing | 0 | 2 | 8 |
| Cash from financing | 2 | -116 | -134 |
| Net cash flow | 2 | 325 | 48 |
| Free cash flow | -4 | 429 | 167 |
| CFO / operating profit | 2% | 208% | 85% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Sanofi Consumer Healthcare India Ltd operating ratios
| Per year | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| ROCE % | — | 111% | 90% |
| Debtor days | 21 | 7 | 12 |
| Inventory days | 232 | 80 | 98 |
| Days payable | 144 | 138 | 126 |
| Cash conversion cycle | 109 | -51 | -16 |
| Working capital days | 134 | -33 | -4 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Sanofi Consumer Healthcare India Ltd shareholding pattern
Promoters held 71.27% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.60% and DIIs 17.85%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 60.40% | 60.40% | 60.40% | 71.27% | 71.27% | 71.27% | 71.27% | 71.27% |
| FIIs | 5.22% | 4.42% | 4.52% | 3.24% | 2.94% | 2.83% | 2.76% | 2.60% |
| DIIs | 23.83% | 25.35% | 25.48% | 16.89% | 17.21% | 17.33% | 17.57% | 17.85% |
| Public | 10.56% | 9.84% | 9.59% | 8.59% | 8.58% | 8.57% | 8.41% | 8.28% |
| No. of shareholders | 58,582 | 55,734 | 51,859 | 49,632 | 48,808 | 48,075 | 48,418 | 47,511 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Sanofi Consumer Healthcare India Ltd corporate filings
- Intimation for Closure of Trading Window.Insider Trading / SASTlow impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.